HTRA1 and neoplasm: Eventually, 15 papers assessing HtrA1 expression at 10 tumours sites (stomach, liver, bladder, breast, esophagus, thyroid, endometrium, pleura, ovary, colorectum cancer) were included in the meta-analysis [9–13, 15, 17, 34–41].